The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing

The Lead

Report: Manufacturing Skills Gap Could Hit 2M Jobs By 2025

October 12, 2015 | by Andy Szal, Digital Reporter | News | Comments

A new report estimates that a majority of needed manufacturing jobs could go unfilled over the next decade if changes aren't made.

View Sample

FREE Daily Email Newsletter

Glancy Prongay & Murray LLP Announces Investigation of Amicus Therapeutics

October 12, 2015 11:42 am | by Business Wire | News | Comments

Glancy Prongay & Murray LLP announces that it is investigating potential claims on behalf of investors of Amicus Therapeutics, Inc.


Teva Announces Exclusive Launch of Generic Capsules in the U.S.

October 12, 2015 11:25 am | by Business Wire | News | Comments

Teva Pharmaceutical Industries Ltd. announced the exclusive launch of generic capsules in the United States. 


Sunshine Biopharma Acquires U.S. Patent

October 9, 2015 3:50 pm | by Marketwired | News | Comments

Sunshine Biopharma Inc. announces that it has acquired a U.S. patent.


Medline Industries, Inc. Issues a Voluntary Nationwide Recall

October 9, 2015 3:38 pm | by Business Wire | News | Comments

Medline Industries, Inc. announced that it will initiate a voluntary nationwide recall of lot of tablets.


Ohio Challenges FDA's Stand on Execution Drug

October 9, 2015 3:31 pm | by The Associated Press | News | Comments

Ohio sent a forceful letter to Washington on Friday asserting that the state believes it can obtain a lethal-injection drug from overseas without violating any laws.


Bristol-Myers Squibb’s Drug Receives Expanded FDA Approval

October 9, 2015 3:17 pm | by Business Wire | News | Comments

Bristol-Myers Squibb Company announced that the FDA has approved their drug, for intravenous use, for the treatment of patients with metastatic NSCLC with progression on or after platinum-based chemotherapy.


Uniquity 2015, Day 2: Global Counterfeiting & Company/Consumer Safety

October 9, 2015 2:56 pm | by Meg Snyder, Editor, @PharmProEditor | Blogs | Comments

On the second and final day of Systech’s 2015 Uniquity Global Conference, speakers delved into topics such as global counterfeiting, company safety, and consumer safety.


Uniquity 2015, Day 1: Delving Into the Future & Implementation of Serialization

October 8, 2015 6:15 pm | by Meg Snyder, Editor, @PharmProEditor | Blogs | Comments

The first day of the 2015 Uniquity conference concludes, but not without giving attendees much to ponder on regarding serialization.


FDA Accepted Vertex Pharmaceutical's sNDA for Priority Review

October 7, 2015 5:35 pm | by Business Wire | News | Comments

Vertex Pharmaceuticals Incorporated announced that the FDA has accepted for review a sNDA for a drug that treats CF in people ages 2 and older who have one of 23 residual function mutations. 


Nektar Submits Investigational New Drug Application for Solid Tumor Malignancies Treatment

October 7, 2015 5:23 pm | by PR Newswire | News | Comments

Nektar Therapeutics announced that it has submitted an IND application to the FDA for its lead immuno-oncology candidate.


Marathon Pharmaceuticals Receives Rare Pediatric Disease Designation from FDA

October 7, 2015 5:15 pm | by Business Wire | News | Comments

Marathon Pharmaceuticals announced that the FDA has granted rare pediatric disease designation for a potential treatment for patients with DMD.


Amicus Therapeutics, Inc. Sued for Securities Fraud After Revealing Its NDA Will Not Be Filed This Year

October 7, 2015 5:08 pm | by PR Newswire | News | Comments

Amicus Therapeutics, Inc. and its Chief Executive Officer, John F. Crowley, were named as defendants in a lawsuit.


Illinois Claimants Opt-In to Takeda Pharmaceutical’s $2.4 Billion Product Liability Resolution Program

October 7, 2015 4:51 pm | by Business Wire | News | Comments

Meyers & Flowers Law Firm announces Illinois claimants opt-in to Takeda Pharmaceutical’s $2.4 billion liability resolution program.


FDA Clears the Focus Diagnostics Direct Test to Include New Virus Strains for Flu Season

October 7, 2015 10:33 am | by PR Newswire | News | Comments

In advance of the 2015-2016 flu season, Focus Diagnostics announced that its SimplexaT Flu A/B & RSV Direct Kit has received clearance from the FDA for additional strains.


Express Scripts to Cover Pricey New Cholesterol Treatments

October 7, 2015 10:07 am | by Tom Murphy, AP Business Writer | News | Comments

Express Scripts has decided to cover two new drugs that lower cholesterol.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.